J. B. Chemicals & Pharmaceuticals Limited

NSEI:JBCHEPHARM 株式レポート

時価総額：₹278.0b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

J. B. Chemicals & Pharmaceuticals 将来の成長

Future 基準チェック /46

J. B. Chemicals & Pharmaceuticals利益と収益がそれぞれ年間17.9%と11.7%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に21.4% 17.6%なると予測されています。

主要情報

17.6%

収益成長率

17.4%

EPS成長率

Pharmaceuticals 収益成長17.1%
収益成長率11.9%
将来の株主資本利益率21.4%
アナリストカバレッジ

Good

最終更新日01 Jul 2024

今後の成長に関する最新情報

J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 09
J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

Recent updates

These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

Jun 28
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Apr 19
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 09
J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Dec 22
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 29
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

Aug 03
J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Feb 11
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

Dec 03
Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Sep 21
A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Aug 03
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Jun 15
Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

Mar 29
Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

Feb 16
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting

Jan 27
With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt

Nov 30
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt

Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today

Sep 24
Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today

Are J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Investors Paying Above The Intrinsic Value?

Aug 03
Are J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Investors Paying Above The Intrinsic Value?

Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?

Jun 14
Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?

How Does J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Fare As A Dividend Stock?

May 04
How Does J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Fare As A Dividend Stock?

業績と収益の成長予測

NSEI:JBCHEPHARM - アナリストの将来予測と過去の財務データ ( )INR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
3/31/202751,3819,935-99310,5766
3/31/202645,8458,5817,9418,92412
3/31/202540,5596,9846,4597,57514
3/31/202435,2155,5265,3938,006N/A
12/31/202333,8485,141N/AN/AN/A
9/30/202333,3304,8662,8887,680N/A
6/30/202332,6074,471N/AN/AN/A
3/31/202331,4934,098-1,3936,256N/A
12/31/202230,1154,071N/AN/AN/A
9/30/202228,1953,848-7,3793,122N/A
6/30/202226,0313,715N/AN/AN/A
3/31/202224,2423,854-5,3671,701N/A
12/31/202123,2814,011N/AN/AN/A
9/30/202122,7574,7133,1543,745N/A
6/30/202121,2624,474N/AN/AN/A
3/31/202120,4254,4802,6703,148N/A
12/31/202019,5763,975N/AN/AN/A
9/30/202018,3813,0971,1781,786N/A
6/30/202018,5093,295N/AN/AN/A
3/31/202017,7472,7202,0282,757N/A
12/31/201917,5012,686N/AN/AN/A
9/30/201917,0352,5212,1482,749N/A
6/30/201916,8242,098N/AN/AN/A
3/31/201916,4321,9351,4521,943N/A
3/31/201814,0841,3838651,229N/A
3/31/201713,4431,841N/A2,011N/A
3/31/201612,1041,625N/A1,404N/A
3/31/201511,4421,004N/A1,267N/A
3/31/201410,219615N/A-140N/A

アナリストによる今後の成長予測

収入対貯蓄率: JBCHEPHARMの予測収益成長率 (年間17.9% ) は 貯蓄率 ( 6.7% ) を上回っています。

収益対市場: JBCHEPHARMの収益 ( 17.9% ) はIndian市場 ( 15.9% ) よりも速いペースで成長すると予測されています。

高成長収益: JBCHEPHARMの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: JBCHEPHARMの収益 ( 11.7% ) Indian市場 ( 9.5% ) よりも速いペースで成長すると予測されています。

高い収益成長: JBCHEPHARMの収益 ( 11.7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: JBCHEPHARMの 自己資本利益率 は、3年後には高くなると予測されています ( 21.4 %)

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y